• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BIR
Click for more information
0.00% 1.4¢

BIR FINANCIAL LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
BIR
Ann: Half Yearly Report and Accounts 		14:38 0 396
14:38 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  396 
BIR
Ann: Details of Company Address 		19/02/19 0 314
19/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  314 
BIR
Ann: Becoming a substantial holder 		08/02/19 0 241
08/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  241 
BIR
Ann: Appendix 4C - quarterly 		31/01/19 0 72
31/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  72 
BIR
Ann: Response to ASX Appendix 3Y Query 		29/01/19 0 212
29/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  212 
BIR
Ann: Change of Director's Interest Notice 		24/01/19 0 109
24/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  109 
BIR
Ann: Change of Director's Interest Notice 		31/12/18 0 135
31/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  135 
BIR
Ann: Results of Meeting 		30/11/18 0 116
30/11/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  116 

See All Discussions arrow Created with Sketch.

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico? De Grey Mining on Friday denied reports that it's received a takeover offer from Canada-based Agnico Eagle.
The winners & losers on market if negative gearing were gone Removing negative gearing would likely cause a seismic shift in investor behaviour. If that advantage were taken away, more investors might start eyeing the stock market...
ACCC seeks Olam divestments before it can buy Namoi Cotton Australia's market regulator the ACCC has expressed further concerns about the potential takeover of Namoi Cotton by Olam Agri.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.